| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/15/2005 | EP1001979B1 Cyclic azapeptides with angiogenic effect |
| 06/15/2005 | EP0975608B1 Halo-alkoxycarbonyl prodrugs |
| 06/15/2005 | EP0923555B1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |
| 06/15/2005 | CN1628128A Mammal prolactin variants |
| 06/15/2005 | CN1628126A Modified transferrin fusion proteins |
| 06/15/2005 | CN1628116A Inhibitors of alpha l beta 2 integrin mediated cell adhesion |
| 06/15/2005 | CN1628113A Substituted indoles as alpha-1 agonists |
| 06/15/2005 | CN1628107A Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors |
| 06/15/2005 | CN1628101A 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6 |
| 06/15/2005 | CN1628099A Water soluble phenylglycine derivatives |
| 06/15/2005 | CN1626228A Extractive from decoction of rehmannia including six elements, combination of medication, and medical use |
| 06/15/2005 | CN1626208A Preparation of fleabane and preparation method |
| 06/15/2005 | CN1626207A Preparation including unique ingredient and fabricating method |
| 06/15/2005 | CN1626197A Method for preparing external and internal remedies for treating diseases of AIDS, ulcer of oral cavity, burn and scald, and usage |
| 06/15/2005 | CN1626179A Solid preparation of 'Fuxiekang' and preparation method |
| 06/15/2005 | CN1626156A Method for preparing liquid for raising white blood cell |
| 06/15/2005 | CN1626071A Propylgallate injection administration does type and preparation method |
| 06/15/2005 | CN1626068A Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 06/15/2005 | CN1205950C Sanweishenxue capsule for treating aplastic anemia and its preparation technology |
| 06/14/2005 | US6906084 Indole derivatives as factor Xa inhibitors |
| 06/14/2005 | US6906068 Substituted polycyclic aryl and heteroaryl 1,2,4 - triazinones useful as anticoagulants |
| 06/14/2005 | US6906063 For therapy and prophylaxis of thrombosis in a mammal |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906033 Isolated DNA encoding amino acid sequences, serine protease inhibitor, host cell transformed with a DNA molecule, Kunitz type Inhibitor, blood coagulation factors |
| 06/14/2005 | US6905846 Nucleic acids encoding factor X deletion mutants and analogues thereof |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905676 Cytokines; anttumor agents; viricides; bactericides; antiinflammatory agents |
| 06/14/2005 | CA2150229C Nitric esters having a pharmacological activity and process for their preparation |
| 06/14/2005 | CA2112017C Use of benzothiophenes for lowering serum cholesterol |
| 06/09/2005 | WO2005051934A1 Antithrombotic compounds with dual function |
| 06/09/2005 | WO2005051913A1 Cyclic amine derivative having heteroaryl ring |
| 06/09/2005 | WO2005051912A1 Piperidine compound and method for producing same |
| 06/09/2005 | WO2005014021A3 Use of zkw peptide for preparing an inhibitor drug against platelet aggregation |
| 06/09/2005 | US20050124927 Blood processing systems and methods that alternate flow of blood component and additive solution through an in-line leukofilter |
| 06/09/2005 | US20050124649 Deazapurines and uses thereof |
| 06/09/2005 | US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease |
| 06/09/2005 | US20050124621 Novel inhibitors of kinases |
| 06/09/2005 | US20050124605 E.g., substituted 2,3,5,10b-tetraaza-benzo[e]azulen-6-yl)-acetic acids, 2,3,4,5-tetrahydro-1H-benzo[e][1,4]diazepin-5-yl)-(4,6-dimethoxy-pyrimidin-2-yloxy)-acetic acids and 2,3,4,5-tetrahydro-benzo[e][1,4]diazepin-1-ylmethyl}-benzoates; treating circulatory, inflammatory, and proliferative disorders |
| 06/09/2005 | US20050124586 Alpha-substituted arylalkyl phosphonate derivatives |
| 06/09/2005 | US20050124581 Alpha-substituted heteroarylalkyl phosphonate derivatives |
| 06/09/2005 | US20050124577 8-Azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| 06/09/2005 | US20050124544 Peptide decoys for the preparation of medicaments intended for the prevention or treatment of autoimmune pathologies or disorders linked to the appearance of antibodies directed against exogenous proteins |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124036 Method for producing recombinant proteins in micro-organisms |
| 06/09/2005 | US20050124003 Using immunoaffinity selection to isolate and propagate pluripotent stem cell populations from fetal developmental tissues; cell replacement therapies |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches |
| 06/09/2005 | US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate |
| 06/09/2005 | US20050123617 Biodegradable polymeric nanocapsules and uses thereof |
| 06/09/2005 | US20050123605 Anticancer agents; prevent forming blood vessels; removal blockage |
| 06/09/2005 | US20050123508 human granulocyte colony stimulating factor polypeptides having amino acid replacements in the sequence, used for treating hematopoietic, neurological or reproductive disorders |
| 06/09/2005 | CA2547472A1 Cyclic amine derivative having heteroaryl ring |
| 06/09/2005 | CA2547467A1 Piperidine compound and method for producing same |
| 06/09/2005 | CA2547235A1 T-type calcium channel blocker |
| 06/09/2005 | CA2536188A1 Electrical devices and anti-scarring agents |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537102A1 Inhibition of phsphoinostide 3-dinase beta |
| 06/08/2005 | EP1537075A2 Diarylurea derivatives and their use as chloride channel blockers |
| 06/08/2005 | EP1536863A1 Use of cyclooxygenase-2 selective inhibitors and thrombolytic agents for the treatment or prevention of a vaso-occlusive event |
| 06/08/2005 | EP1536823A1 Use of erythopoietin |
| 06/08/2005 | EP1536822A1 Stable pharmaceutical composition comprising erythropoietin |
| 06/08/2005 | EP1536778A2 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 06/08/2005 | EP1536688A2 Mammalian megakaryocyte progenitor cell |
| 06/08/2005 | EP1373269B1 Jun kinase inhibitors |
| 06/08/2005 | EP1309575B1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 06/08/2005 | EP1252133B1 Pharmaceutical compounds |
| 06/08/2005 | EP1189895B1 Thiazole and oxazole derivatives and their pharmaceutical use |
| 06/08/2005 | EP1176146B1 Carbamoyl tetrahydropyridine derivatives |
| 06/08/2005 | EP1019045B1 Antithrombotic agents |
| 06/08/2005 | EP0983304B1 Dermatan disulfate, an inhibitor of thrombin generation and complement activation |
| 06/08/2005 | CN1625559A Novel compounds that inhibit factor Xa activity |
| 06/08/2005 | CN1625558A Aza-arylpiperazines |
| 06/08/2005 | CN1625412A Aldosterone antagonist and non-steroidal anti-inflammatory agent combination therapy to prevent or treat cardiovascular disorders |
| 06/08/2005 | CN1625405A Combinations comprising cox-2 inhibitors and aspirin |
| 06/08/2005 | CN1625404A Aldosterone receptor antagonist and alpha-adrenergic modulating agent combination therapy for prevention or treatment of cardiovascular conditions |
| 06/08/2005 | CN1625398A A combination treatment for acute myocardial infarction |
| 06/08/2005 | CN1623582A Chinese medicinal decoction for treating embolus disease |
| 06/08/2005 | CN1623538A Tanshinone II A sulfonic acid or tanshinone II A sodium sulfonate freeze-dried powder injection and its preparation method |
| 06/08/2005 | CN1623535A Medicinal composition for treating bleeding disease and its use |
| 06/08/2005 | CN1205187C New amidino derivatives and their use as thrombin inhibitors |
| 06/08/2005 | CN1205183C New amidino derivatives and their use as thrombin inhibitors |
| 06/08/2005 | CN1205172C Crystals of sodium salt of pravastatin |
| 06/08/2005 | CN1204889C Adhesion receptor antagonists |
| 06/08/2005 | CN1204885C Pharmaceutical composition contg. fenofibrate and preparation method |
| 06/07/2005 | US6903220 Synthesis of chiral 2-alkyl amino acids |
| 06/07/2005 | US6903135 Methods and products related to 16-HETE analogs |
| 06/07/2005 | US6903131 Administering to a patient an antiangiogenesis or anticancer agent (N,N-disubstituted-3,4-diamino-2,4-dione-pyrroline derivatives for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer |
| 06/07/2005 | US6903115 Bipiperidine compounds |
| 06/07/2005 | US6903107 Serine protease inhibitor |
| 06/07/2005 | US6903096 Quinazoline derivatives as medicaments |
| 06/07/2005 | US6903089 Lactam-substituted pyrazolopyridine derivatives |
| 06/07/2005 | US6903088 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 06/07/2005 | US6903087 Pyrido cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists |
| 06/07/2005 | US6903086 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as IP antagonists |
| 06/07/2005 | CA2091789C Method of inhibiting microvascular thrombosis |
| 06/07/2005 | CA2051693C Allosteric hemoglobin modifiers |
| 06/02/2005 | WO2005049070A1 Therapeutic use of factor xi |
| 06/02/2005 | WO2005013884A3 Methods for preventing neurological events |
| 06/02/2005 | WO2004093797A3 Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots |
| 06/02/2005 | WO2003090514A3 Adipocyte complement related protein zacrp14 |